The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation.
Saved in:
| Title: | The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation. |
|---|---|
| Authors: | Smith, Katie J.1 (AUTHOR), Minns, Danielle1 (AUTHOR), McHugh, Brian J.1 (AUTHOR), Holloway, Rebecca K.2,3 (AUTHOR), O'Connor, Richard1 (AUTHOR), Williams, Anna4 (AUTHOR), Melrose, Lauren1 (AUTHOR), McPherson, Rhoanne1 (AUTHOR), Miron, Veronique E.2 (AUTHOR), Davidson, Donald J.1 (AUTHOR), Gwyer Findlay, Emily1 (AUTHOR) Emily.findlay@ed.ac.uk |
| Source: | PLoS Biology. 8/26/2022, Vol. 20 Issue 8, p1-27. 27p. 7 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
